Pharmaceuticals, Biotechnology and Life Sciences
MONTREAL–(BUSINESS WIRE)–#CB1blocker–Inversago Pharma Inc. (“the Company” or “Inversago”), the peripheral CB1 blockade company, today announced it has initiated a Phase…
Research alliance will leverage advanced data analytics and genomic testing to improve recruitment of patients in oncology clinical trials STAMFORD,…
Research alliance will leverage advanced data analytics and genomic testing to improve recruitment of patients in oncology clinical trials STAMFORD,…
Research alliance will leverage advanced data analytics and genomic testing to improve recruitment of patients in oncology clinical trials STAMFORD,…
Research alliance will leverage advanced data analytics and genomic testing to improve recruitment of patients in oncology clinical trials STAMFORD,…
SEOUL, South Korea–(BUSINESS WIRE)–#AI–Standigm Inc. (“Standigm”), an artificial intelligence (AI)-based drug discovery company, and SK holdings C&C, Co., Ltd. (“SK…
SEOUL, South Korea–(BUSINESS WIRE)–#AI–Standigm Inc. (“Standigm”), an artificial intelligence (AI)-based drug discovery company, and SK holdings C&C, Co., Ltd. (“SK…
SEOUL, South Korea–(BUSINESS WIRE)–#AI–Standigm Inc. (“Standigm”), an artificial intelligence (AI)-based drug discovery company, and SK holdings C&C, Co., Ltd. (“SK…
SEOUL, South Korea–(BUSINESS WIRE)–#AI–Standigm Inc. (“Standigm”), an artificial intelligence (AI)-based drug discovery company, and SK holdings C&C, Co., Ltd. (“SK…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Vor Biopharma, an oncology company pioneering engineered hematopoietic stem cells (eHSCs) for the treatment of cancer, and Arbor…